Skip to content
Off-topic for aiqbench

Off-topic for aiqbench

This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.

Eli Lilly shares drop 7% in one month, but Citigroup sets $1,600 price target citing Mounjaro and Zepbound's $14.9B quarterly revenue

Dealroom.co1 min read

Eli Lilly shares drop 7% in one month, but Citigroup sets $1,600 price target citing Mounjaro and Zepbound's $14.9B quarterly revenue  Dealroom

Read the full article at Dealroom.co

Related coverage